H. Dopeso

发表

RHOA inactivation enhances Wnt signaling and promotes colorectal cancer

John M. Mariadason, Josep Tabernero, D. Arango, 2014, Nature Communications.

An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression.

Sanjay Goel, Kenneth Fordyce, Ziqiang Yuan, 2009, Cancer research.

EPHB 4 and Survival of Colorectal Cancer Patients

Andrew J. Wilson, L. Aaltonen, D. Arango, 2006 .

EPHB4 and survival of colorectal cancer patients.

Andrew J. Wilson, John M Mariadason, L. Aaltonen, 2006, Cancer research.

PHD3 regulates EGFR internalization and signalling in tumours

T. Acker, S. Seidel, A. Acker-Palmer, 2014, Nature Communications.

Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression

D. Arango, O. Sieber, W. Shi, 2022, Cell Death & Differentiation.

Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix

S. Chandarlapaty, J. Reis-Filho, B. Weigelt, 2022, The Journal of pathology.

KIT genetic alterations in breast cancer

J. Reis-Filho, B. Weigelt, E. Brogi, 2022, Journal of Clinical Pathology.

Myosin Vb as a tumor suppressor gene in intestinal cancer

D. Arango, S. Schwartz, X. Matías-Guiu, 2022, Oncogene.

University of Groningen Myo 5 b knockout mice as a model of microvillus inclusion disease

D. Arango, S. Schwartz, S. Y. Cajal, 2017 .

Myo5b knockout mice as a model of microvillus inclusion disease

D. Arango, S. Schwartz, S. V. van IJzendoorn, 2015, Scientific Reports.

High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability

D. Arango, R. Hofstra, R. Hofstra, 2007, Oncogene.

Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR

G. Reifenberger, P. Carmeliet, T. Acker, 2014, Nature Communications.

PVT1 Long Non-coding RNA in Gastrointestinal Cancer

D. Arango, H. Dopeso, Águeda Martínez-Barriocanal, 2020, Frontiers in Oncology.

Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary

J. Reis-Filho, B. Weigelt, E. Oliva, 2020, Nature Communications.

Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary

J. Reis-Filho, B. Weigelt, E. Oliva, 2020, Nature Communications.

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer

D. Arango, J. Mariadason, M. Segura, 2017, British Journal of Cancer.

Brush border Myosin Ia has tumor suppressor activity in the intestine

M. Kloor, L. Aaltonen, D. Arango, 2012, Proceedings of the National Academy of Sciences.

Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.

J. Reis-Filho, B. Weigelt, D. Chi, 2022, Gynecologic oncology.

Oncogenic properties and signaling basis of the PAX8‐GLIS3 fusion gene

J. Reis-Filho, B. Weigelt, M. Papotti, 2020, International journal of cancer.

The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.

Andrew J. Wilson, D. Arango, J. Mariadason, 2009, Cancer research.

Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis

L. Aaltonen, D. Arango, J. Mariadason, 2021, Clinical epigenetics.

Brush border myosin Ia inactivation in gastric but not endometrial tumors

D. Arango, R. Hofstra, J. Mariadason, 2013, International journal of cancer.

Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment

Andrew J. Wilson, D. Arango, J. Mariadason, 2010, Clinical Cancer Research.

PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.

T. Acker, M. Kracht, A. Acker-Palmer, 2018, Cancer research.

Villin expression is frequently lost in poorly differentiated colon cancer.

L. Aaltonen, D. Arango, J. Mariadason, 2012, The American journal of pathology.

Loss of the EPH receptor B6 contributes to colorectal cancer metastasis

D. Arango, J. Mariadason, S. Schwartz, 2017, Scientific Reports.

Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment

D. Arango, J. Mariadason, S. Schwartz, 2015, Clinical Cancer Research.

Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites

S. Chandarlapaty, J. Reis-Filho, A. Vincent-Salomon, 2020, Journal of Clinical Pathology.

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer

S. Chandarlapaty, J. Reis-Filho, L. Norton, 2021, NPJ breast cancer.

Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families

D. Arango, G. Capellá, S. Schwartz, 2008, International journal of cancer.

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer

S. Chandarlapaty, J. Reis-Filho, L. Norton, 2021, npj Breast Cancer.

Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer

D. Arango, S. Schwartz, S. Landolfi, 2017, Scientific Reports.

Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?

Adrian V. Lee, J. Fine, J. Reis-Filho, 2023, NPJ breast cancer.